caffeine / dimenhydrinate / scopolamine
- RxCUI
- 1008691
- RxNorm name
- caffeine / dimenhydrinate / scopolamine
- Term type
- MIN
- Status
- Active
- Updated
- 2026-10-29 05:59:50
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| caffeine | 1886 |
| dimenhydrinate | 3444 |
| scopolamine | 9601 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | caffeine / dimenhyDRINATE / scopolamine | 1 | NAMES |
| RxNorm Name | caffeine / dimenhydrinate / scopolamine | 1 | NAMES |
| TTY | MIN | 1 | ATTRIBUTES |
| RxCUI | 1008691 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R06AA | Aminoalkyl ethers | ATC1-4 | dimenhydrinate | |
| ATC | S01FA | Anticholinergics | ATC1-4 | scopolamine | |
| ATC | A04AD | Other antiemetics | ATC1-4 | scopolamine | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | N05CM | Other hypnotics and sedatives | ATC1-4 | scopolamine | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175574 | Anticholinergic | EPC | has_epc | scopolamine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175370 | Cholinergic Antagonists | MOA | has_moa | scopolamine |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D004111 | Dimenhydrinate | CHEM | has_ingredient | dimenhydrinate |
| MEDRT | D012601 | Scopolamine | CHEM | has_ingredient | scopolamine |
| MEDRT | D000647 | Amnesia | DISEASE | induces | scopolamine |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D003108 | Colonic Diseases | DISEASE | may_treat | scopolamine |
| MEDRT | D004238 | Diverticulitis | DISEASE | may_treat | scopolamine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | scopolamine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dimenhydrinate |
| MEDRT | D004403 | Dysentery | DISEASE | may_treat | scopolamine |
| MEDRT | D005158 | Facial Paralysis | DISEASE | may_treat | scopolamine |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | scopolamine |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | scopolamine |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | scopolamine |
| MEDRT | D015863 | Iridocyclitis | DISEASE | may_treat | scopolamine |
| MEDRT | D009041 | Motion Sickness | DISEASE | may_prevent | scopolamine |
| MEDRT | D009041 | Motion Sickness | DISEASE | may_treat | dimenhydrinate |
| MEDRT | D009157 | Myasthenia Gravis | DISEASE | ci_with | scopolamine |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | scopolamine |
| MEDRT | D009325 | Nausea | DISEASE | may_prevent | scopolamine |
| MEDRT | D009325 | Nausea | DISEASE | may_prevent | dimenhydrinate |
| MEDRT | D009325 | Nausea | DISEASE | may_treat | dimenhydrinate |
| MEDRT | D010301 | Parkinson Disease, Postencephalitic | DISEASE | may_treat | scopolamine |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | scopolamine |
| MEDRT | D013610 | Tachycardia | DISEASE | ci_with | scopolamine |
| MEDRT | D013971 | Thyrotoxicosis | DISEASE | ci_with | scopolamine |
| MEDRT | D014717 | Vertigo | DISEASE | may_prevent | dimenhydrinate |
| MEDRT | D014717 | Vertigo | DISEASE | may_treat | dimenhydrinate |
| MEDRT | D014839 | Vomiting | DISEASE | may_treat | dimenhydrinate |
| MEDRT | D014839 | Vomiting | DISEASE | may_prevent | scopolamine |
| MEDRT | D014839 | Vomiting | DISEASE | may_prevent | dimenhydrinate |
| MEDRT | N0000000125 | Cholinergic Muscarinic Antagonists | MOA | has_moa | scopolamine |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | dimenhydrinate |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | scopolamine |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | scopolamine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008635 | Decreased GI Motility | PE | has_pe | scopolamine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | scopolamine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | dimenhydrinate |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | scopolamine |
| MEDRT | N0000008779 | Decreased Parasympathetic Acetylcholine Activity | PE | has_pe | scopolamine |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | scopolamine |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000009808 | Positive Chronotropy | PE | has_pe | scopolamine |
| MEDRT | N0000009820 | Pupillary Dilation | PE | has_pe | scopolamine |
| MEDRT | N0000009842 | Salivation Inhibition | PE | has_pe | scopolamine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| NAMES | Tallman Synonym | caffeine / dimenhyDRINATE / scopolamine |